Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Therapy with CSII in Newly Diagnosed Type 2 Diabetes
NCT00948324Phase 4Suspended
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2008
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 4 trial of human insulin, alpha-lipoic acid, rosiglitazone, metformin in type 2 diabetes mellitus (T2DM), sponsored by Sun Yat-sen University. Started Jun 2008; status: suspended.
02
Drugs
human insulinalpha-lipoic acidrosiglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00948324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948324.